ERBB2 and ameloblastoma: Rotellini et al. [55] designed a study to examine the expression of several cancer-related proteins, including cellular tumor antigen p53 (TP53), serine/threonine-protein kinase B-Raf (BRAF), and EGFR, as well as ERBB2 in maxillary ameloblastoma.